ExLibris header image
SFX Logo
Title: Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
Source:

Nature Medicine [1078-8956] Ries, Stefan yr:2000


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Xie, K. "Interleukin-8 and human cancer biology." Cytokine & growth factor reviews 12.4: 375-391. Link to SFX for this item
2. Normand, G. "p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity." Journal of biological chemistry 280.8 (2005): 7118-30. Link to Full Text for this item Link to SFX for this item
3. Heise, C. "An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy." Nature medicine 6.10 (2000): 1134-1139. Link to Full Text for this item Link to SFX for this item
4. Mantovani, A. "Cancer-related inflammation." Nature 454.7203 (2008): 436-44. Link to Full Text for this item Link to SFX for this item
5. Heise, C. "ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents." Nature medicine 3.6: 639-645. Link to SFX for this item
6. Williams, B R R. "PKR; a sentinel kinase for cellular stress." Oncogene 18.45 (1999): 6112-20. Link to Full Text for this item Link to SFX for this item
7. Koch, R M M. "Interleukin-8 as a macrophage-derived mediator of angiogenesis." Science 258.5089 (1993): 1798-801. Link to SFX for this item
8. Kubba, H. "The aetiology of otitis media with effusion: a review." Clinical otolaryngology and allied sciences 25.3 (2000): 181-94. Link to Full Text for this item Link to SFX for this item
9. Nettelbeck, Dirk M M. "Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer." Journal of molecular medicine 86.4 (2008): 363-377. Link to Full Text for this item Link to SFX for this item
10. Haqqani, A S S. "Constitutive expression of interleukin-8 by Mutatect cells markedly affects their tumor biology." Carcinogenesis 243-250. Link to SFX for this item
11. Sherr, Charles J J. "The RB and p53 pathways in cancer." Cancer cell 2.2: 103-112. Link to SFX for this item
12. Balkwill, F. "Smoldering and polarized inflammation in the initiation and promotion of malignant disease." Cancer cell 7.3: 211-217. Link to SFX for this item
13. Kirn, D. "Replication-selective virotherapy for cancer: Biological principles, risk management and future directions." Nature medicine 7.7: 781-787. Link to SFX for this item
14. Coussens, Lisa M M. "Inflammation and cancer." Nature 420.6917 (2002): 860-7. Link to Full Text for this item Link to SFX for this item
15. Mantovani, A. "Inflammation and cancer: back to Virchow?" Lancet, The 357.9255 (2001): 539-45. Link to SFX for this item
16. Levine, Philip W J. "P53 is a tumor suppressor gene." Cell 116.2 Suppl (2004): 67-9. Link to SFX for this item
17. Grivennikov, Michael I. "Immunity, Inflammation, and Cancer." Cell 140.6 (2010): 883-899. Link to SFX for this item
18. Druker, B J J. "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia." The New England journal of medicine 344.14 (2001): 1031-7. Link to SFX for this item
19. Kinzler, Kenneth W W. "Cancer genes and the pathways they control." Nature medicine 10.8 (2004): 789-99. Link to Full Text for this item Link to SFX for this item
20. Steeg, Patricia S S. "Tumor metastasis: mechanistic insights and clinical challenges." Nature medicine 12.8 (2006): 895-904. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced